JP Morgan Initiates Coverage On Senti Biosciences with Neutral Rating

JP Morgan analyst Brian Cheng initiates coverage on Senti Biosciences (NASDAQ:SNTI) with a Neutral rating.

JP Morgan analyst Brian Cheng initiates coverage on Senti Biosciences (NASDAQ:SNTI) with a Neutral rating.

Total
0
Shares
Related Posts
Read More

S&P 500 Snaps 5-Session Losing Streak But Investor Sentiment Eases

The CNN Money Fear and Greed index showed slight easing in the market sentiment despite US stocks recording gains on Thursday. The S&P 500 closed higher in the previous session, ending its longest losing streak since October. Data released Thursday showed a modest rise in jobless claims, with continuing claims reaching their highest level since February.

GME